← Open Payments lookup

KESTON TRAMMELL: Open Payments

NPI 1427430974 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$896 in 33 payments from 13 companies in 2025. Trend: 2023 $691 · 2024 $1,306 · 2025 $896

Food & beverage: $859Education: $37
CompanyPaymentsAmount
Amgen Inc.3$141
Merck Sharp & Dohme LLC8$137
Medtronic, Inc.2$119
Lilly USA, LLC1$115
Boehringer Ingelheim Pharmaceuticals, Inc.4$73
Novo Nordisk Inc1$60
Novartis Pharmaceuticals Corporation3$50
SCPHARMACEUTICALS INC.3$48
AstraZeneca Pharmaceuticals LP3$47
PFIZER INC.2$40

Products named: REPATHA, VERQUVO, SYMPLICITY G3, JARDIANCE, Ozempic, FUROSCIX, FARXIGA, LEQVIO.

Industry payments across AL — which companies pay providers there.